Sodertalje, Sweden

Martin Hans Bohlin

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 3.8

ph-index = 8

Forward Citations = 287(Granted Patents)


Location History:

  • Stockholm, SE (2004)
  • Molndal, SE (2007 - 2010)
  • Södertälje, SE (2007 - 2014)
  • Sodertalje, SE (2011 - 2015)
  • Alderley Park, GB (2015)
  • Cheshire, GB (2020)
  • Johanneshov, SE (2000 - 2023)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Innovations of Martin Hans Bohlin

Introduction

Martin Hans Bohlin, located in Södertälje, Sweden, is a prominent inventor with a remarkable portfolio of 27 patents. His work primarily focuses on pharmaceutical innovations, specifically involving the compound odevixibat, aimed at treating various liver diseases.

Latest Patents

Among his recent contributions to the field are two significant patents concerning odevixibat. The first patent, titled "Crystal modifications of odevixibat," relates to new crystal modifications, specifically crystal modifications 1 and 2, alongside a detailed process for preparing crystal modification 1. This invention emphasizes a pharmaceutical composition that utilizes this particular modification in treating a range of medical conditions.

The second patent, named "Pharmaceutical formulation of odevixibat," pertains to a novel pediatric formulation comprised of small particles. This formulation is particularly advantageous for treating liver diseases, including bile acid-dependent conditions such as biliary atresia, progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS), and pediatric cholestatic pruritus. Additionally, this patent includes a process for preparing the pharmaceutical formulation, enhancing its clinical utility.

Career Highlights

Throughout his career, Martin has made significant strides while working with esteemed companies such as AstraZeneca and Elobix AB. His experiences in these organizations have helped him refine his innovative approaches to pharmaceutical development.

Collaborations

Martin Hans Bohlin has collaborated with several notable colleagues, including Ingvar Ymen and Robert Lundqvist. These partnerships have fostered a dynamic environment for innovation and have led to the successful development of groundbreaking pharmaceutical solutions.

Conclusion

Martin Hans Bohlin stands out as an influential figure in the field of pharmaceutical innovation. His diligent work continues to advance the treatment options available for liver diseases, showcasing the vital role of inventors in improving healthcare through inventions and patentable innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…